News

The Hain Celestial Group, Inc. HAIN posted second-quarter fiscal 2026 results, with the top and bottom lines declining year over year. The top line surpassed the consensus mark and the bottom line

Mohawk Industries, Inc. MHK is scheduled to report results for its fourth quarter of 2025 on Feb. 12, after market close.In the last reported quarter, the company’s adjusted earnings per share (EPS)

Pre-market indexes are pulling back slightly this morning, following another record close from the blue-chip Dow on Monday. Spirits are generally higher than they were trying to scale the “wall of

Shares of NIKE Inc. NKE have lost momentum in recent months, pushing it below industry thresholds and portraying a bearish sentiment from a technical standpoint. As a result, the NKE stock slipped

Cincinnati Financial Corporation CINF reported fourth-quarter 2025 operating income of $3.37 per share, which surpassed the Zacks Consensus Estimate by 17.8%. The bottom line increased 7% year over

Arch Capital Group Ltd. ACGL reported fourth-quarter 2025 operating income of $2.98 per share, which beat the Zacks Consensus Estimate by 19.7%. The bottom line increased 31.9% year over year.

Vale S.A. VALE is expected to post year-over-year growth in revenues and earnings when it reports fourth-quarter 2025 results on Feb. 12, after market close.

The Zacks Consensus Estimate for Vale’s

DuPont de Nemours, Inc. DD has registered a fourth-quarter 2025 loss from continuing operations of $108 million or 27 cents per share. In the year-ago quarter, the company recorded a loss of $291

Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2025 adjusted earnings per share (EPS) of $2.42, which beat the Zacks Consensus Estimate by 1.7%. The adjusted figure rose 4.8% year over year.

Equinor ASA EQNR signed a five-year gas supply deal with Dutch gas grid operator Eneco to supply natural gas to the Netherlands. Per the terms of the deal, Equinor will deliver up to 0.5 billion

Eli Lilly LLY announced that it entered a definitive agreement to acquire the privately held clinical-stage biotech Orna Therapeutics in a deal valued at $2.4 billion. This transaction includes both

Bristol Myers’ BMY legacy portfolio — comprising Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane — continues to face significant erosion from generic competition.

Fourth-quarter legacy portfolio

Goodyear Tire GT reported fourth-quarter 2025 adjusted earnings per share of 39 cents, which missed the Zacks Consensus Estimate of 45 cents. The company reported earnings of 39 cents per share in

Harley-Davidson, Inc. HOG reported a loss of $2.44 per share in fourth-quarter 2025, wider than the Zacks Consensus Estimate of a loss of 92 cents. The company had incurred a loss of 93 cents per

Ashland Inc. ASH announced that its agrimer eco-coat polymer seed coating for crop care has been officially posted and approved by the United States Environmental Protection Agency. The new

Sally Beauty Holdings, Inc. SBH reported fiscal first-quarter 2026 results, wherein the top line came slightly below the Zacks Consensus Estimate, while the bottom line beat the Zacks Consensus

Advanced Micro Devices AMD shares have plunged 11% post fourth-quarter 2025 reported on Feb. 3. The company reported non-GAAP earnings of $1.53 per share, which jumped 40.4% year over year and 27.5%

nVent Electric NVT shares have gained 2% since the company reported its fourth-quarter 2025 earnings on Feb. 6. The rise was driven by the strength in data center demand, infrastructure growth

T. Rowe Price Group, Inc. TROW board of directors announced a quarterly dividend of $1.30 per share, representing a 2.4% increase from the prior payout. The dividend will be paid out on March 30

Eli Lilly and Company LLY announced fourth-quarter and full-year results last week. The company delivered robust financial performance in 2025 with revenues of $65.2 billion rising 45% and EPS

We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its fourth-quarter and full-year 2025 results on Feb. 12, after market close. The Zacks Consensus Estimate for the

International Business Machines Corporation’s IBM QRadar Security Information and Event Management (SIEM) and Security Orchestration, Automation and Response (SOAR) platforms have been integrated

Quest Diagnostics Inc.’s DGX fourth-quarter 2025 adjusted earnings per share (EPS) of $2.42 beat the Zacks Consensus Estimate by 2.85%. The metric also exceeded the year-ago adjusted figure by 8.5%.